Sanofi Pasteur Begins Selling Merck's HPV Vaccine Gardasil In Six E.U. Countries

Main Category: Women's Health / Gynecology
Also Included In: Pediatrics / Children's Health;  Pharma Industry / Biotech Industry;  Cervical Cancer / HPV Vaccine
Article Date: 20 Oct 2006 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Healthcare Prof:not yet rated


Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis, recently began selling Merck's human papillomavirus vaccine Gardasil in Austria, Finland, Germany, Ireland, Sweden and the United Kingdom, Reuters reports (Reuters, 10/17). The European Commission late last month approved Gardasil for sale and marketing in the European Union. According to Merck, the vaccine in clinical trials has been shown to be 100% effective in preventing HPV infection with strains 16 and 18, which together cause about 70% of cervical cancer cases, in women who do not already have the virus, and about 99% effective in preventing HPV strains 6 and 11, which together with strains 16 and 18 cause about 90% of genital wart cases. Gardasil also protects against vaginal and vulvar cancers, two other gynecological cancers that are linked to HPV, according to a study presented in June at a meeting of the American Society of Clinical Oncology in Atlanta. In the U.K., the Joint Committee on Vaccination and Immunisation, an independent advisory committee for the U.K. Department of Health, will decide if the vaccine will be covered by the National Health System (Kaiser Daily Women's Health Policy Report, 9/25). Sanofi Pasteur plans to launch sales of the vaccine in most E.U. countries by the end of 2006, but the vaccine will not be available in Italy, Greece or Spain until 2007. According to Reuters, Gardasil in the E.U. will cost between $565 and $753 depending on the country (Reuters, 10/17).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Gardasil.


Article adapted by Medical News Today from original press release.
Visit our women's health / gynecology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Barbara Martin. "Sanofi Pasteur Begins Selling Merck's HPV Vaccine Gardasil In Six E.U. Countries." Medical News Today. MediLexicon, Intl., 20 Oct. 2006. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/54511.php>

APA
Barbara Martin. (2006, October 20). "Sanofi Pasteur Begins Selling Merck's HPV Vaccine Gardasil In Six E.U. Countries." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/54511.php.

Please note: If no author information is provided, the source is cited instead.


Women's Health / Gynecology

Most Popular Articles



Follow Our Women's Health News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Women's Health / Gynecology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »